
Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQ3o2RmRxZ3N6eXVZeWpLNmFNNF9uZ01QZ1pOTGhQZGxUMk1KOTVrbnRpSk4wVzliWll6dnZLck5QWGdTVlZ6VHVJNFNRelRXQVh3VWpUb2dJYlIxck9rMkh5aFB0djUyRXh5eFNnNWloV2g1TlNNWkFWRXJualc4MzRWQy1FbF9rTkZn?oc=5" target="_blank">Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>

